Conclusions
fever
VIRUS, RECURRENCE, INFLUENZA
The safety and effectiveness of single-dose baloxavir were observed in children across all age groups and influenza virus types. Higher rates of fever recurrence and transient virus titer increase were observed in children < 6 years.